NeuroRx, Inc. — Form D
NeuroRx, Inc. of WILMINGTON, DE, a company, filed a Form D exempt-offering notice with the SEC on 2016-11-23. The offering totals $5.5M, of which $4.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-11-23
- Form: D
- Accession: 0001679768-16-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.5M
- Amount sold: $4.5M
- Remaining: $1.0M
- Minimum investment: $40K
- Investors: 11
- Date of first sale: 2016-11-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-275112
Issuer
- Name: NeuroRx, Inc.
- CIK: 0001679768
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 1201 Orange Street, Suite 600, WILMINGTON, DE, 19801
- Phone: 212-643-0417
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Jonathan Javitt | Director | Bethesda, MD |
| Jonathan Javitt | Executive Officer | Bethesda, MD |
| Chaim Hurvitz | Director | Wilmington, DE |
| James Lawrence | Director | Plymouth, MN |
| Sherry Glied | Director | New York, NY |
| Daniel Javitt | Director | Fort Lee, NJ |
Other filings by this issuer (1)
More